An overview of Skp2: a promising new therapeutic target of psoriasis.

Yashika Tomar Moushumi Baidya Jay Chadokiya Shvetank Bhatt Gautam Singhvi

Published in: Expert opinion on therapeutic targets (2024)

Targeting Skp2 holds promise for developing novel therapeutic approaches for psoriasis. By modulating Skp2 activity or expression, it may be possible to intervene in inflammatory and proliferative processes underlying the disease. Further research into Skp2 inhibitors and their efficacy in preclinical and clinical settings is warranted to harness the full potential of Skp2 as a therapeutic target in psoriasis management.

Keyphrases

poor prognosis
atopic dermatitis
oxidative stress
signaling pathway
cancer therapy
cell therapy
binding protein
mesenchymal stem cells
bone marrow
climate change
human health
long non coding rna
artificial intelligence